We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
695
Increased
1,955
Reduced
1,481
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KXIN icon
4101
Kaixin Holdings
KXIN
$8.76M
0
PRFX icon
4102
PRF Technologies Ltd
PRFX
$3.04M
$24K ﹤0.01%
21
+3
+17% +$3.61K
PSHG icon
4103
Performance Shipping
PSHG
$21.6M
$24K ﹤0.01%
2,956
-453
-13% -$13K
BIVI icon
4104
BioVie
BIVI
$11.5M
$23K ﹤0.01%
+160
New +$48K
INM icon
4105
InMed Pharmaceuticals
INM
$7.85M
$23K ﹤0.01%
99
+9
+10% +$3.44K
MSGM icon
4106
Motorsport Games
MSGM
$18.1M
$23K ﹤0.01%
+3,451
New +$28.8K
COMS
4107
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$23K ﹤0.01%
1,334
+731
+121% +$24.9K
EVAX
4108
Evaxion A/S
EVAX
$23.5M
$22K ﹤0.01%
+232
New +$26.5K
SONN
4109
DELISTED
Sonnet BioTherapeutics
SONN
$22K ﹤0.01%
32
-699
-96% -$501K
BCDA icon
4110
BioCardia
BCDA
$12.3M
$21K ﹤0.01%
987
+74
+8% +$1.77K
GLMD icon
4111
Galmed Pharmaceuticals
GLMD
$5.13M
$21K ﹤0.01%
+176
New +$29.2K
PRPO icon
4112
Precipio
PRPO
$38.7M
$21K ﹤0.01%
+1,010
New +$22.9K
SCNI
4113
Scinai Immunotherapeutics
SCNI
$1.41M
$21K ﹤0.01%
+183
New +$25.1K
TAOP icon
4114
Taoping
TAOP
$6.63M
$21K ﹤0.01%
65
-53
-45% -$20.4K
XELB icon
4115
Xcel Brands
XELB
$7.27M
$21K ﹤0.01%
1,745
-1,310
-43% -$17.8K
ZCMD icon
4116
Zhongchao
ZCMD
$6.96M
$21K ﹤0.01%
2
BACK
4117
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$21K ﹤0.01%
858
-855
-50% -$23.7K
KPRX icon
4118
Kiora Pharmaceuticals
KPRX
$11.3M
$20K ﹤0.01%
116
-144
-55% -$24.1K
NRXP icon
4119
NRX Pharmaceuticals
NRXP
$135M
$20K ﹤0.01%
3,290
-10,610
-76% -$139K
RVPH
4120
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$20K ﹤0.01%
910
+275
+43% +$9.63K
TENX icon
4121
Tenax Therapeutics
TENX
$363M
$20K ﹤0.01%
41
-1
-2% -$1K
TMDI
4122
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$20K ﹤0.01%
38,500
-87,147
-69% -$42.6K
VIVE
4123
DELISTED
VIVEVE MED INC
VIVE
$20K ﹤0.01%
29,800
-29,649
-50% -$25.2K
BAOS icon
4124
Baosheng Media Group
BAOS
$920K
$19K ﹤0.01%
2,810
+643
+30% +$6.17K
EZGO
4125
EZGO Technologies
EZGO
$2.09M
0

Similar funds

Renaissance Technologies's Q2 2022 Portfolio in Review

As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
  • Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
  • Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.